Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Regulatory issues in cellular therapies.

Adrian P Gee1

  • 1Center for Cell & Gene Therapy, Baylor College of Medicine, 6621 Fannin Street, MC 3-3320, Houston, Texas 77030, USA. agee@bcm.tmc.edu

Expert Opinion on Biological Therapy
|July 2, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Environmental oxygen affects ex vivo growth and proliferation of mesenchymal progenitors by modulating mitogen-activated protein kinase and mammalian target of rapamycin signaling.

Cytotherapy·2022
Same author

Long-term follow-up for the development of subsequent malignancies in patients treated with genetically modified IECs.

Blood·2022
Same author

The National Heart, Lung, and Blood Institute-funded Production Assistance for Cellular Therapies (PACT) program: Eighteen years of cell therapy.

Clinical and translational science·2021
Same author

A Phase II study of autologous mesenchymal stromal cells and c-kit positive cardiac cells, alone or in combination, in patients with ischaemic heart failure: the CCTRN CONCERT-HF trial.

European journal of heart failure·2021
Same author

T-Cell Therapy for Lymphoma Using Nonengineered Multiantigen-Targeted T Cells Is Safe and Produces Durable Clinical Effects.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2021
Same author

Allogeneic Mesenchymal Cell Therapy in Anthracycline-Induced Cardiomyopathy Heart Failure Patients: The CCTRN SENECA Trial.

JACC. CardioOncology·2021
Same journal

TNF inhibitors for the long-term management of juvenile idiopathic arthritis associated uveitis: real-life data from the ITHACA cohort.

Expert opinion on biological therapy·2026
Same journal

Type 2 inflammation and biologics: a twenty-year journey.

Expert opinion on biological therapy·2026
Same journal

Current outlook on the use of biological agents to improve outcomes in adult secondary hemophagocytic lymphohistiocytosis.

Expert opinion on biological therapy·2026
Same journal

Addressing challenges in disease management of childhood-onset systemic lupus erythematosus: the role of biologics, with primary focus on rituximab and belimumab.

Expert opinion on biological therapy·2026
Same journal

Biological drugs for the treatment of children with atopic dermatitis.

Expert opinion on biological therapy·2026
Same journal

Optimizing biologic therapy in psoriasis: dose adjustment, treatment duration, and tapering-an expert perspective.

Expert opinion on biological therapy·2026
See all related articles

Cellular therapies are advancing rapidly due to better understanding and technology. These innovative treatments show promise for cancer, diabetes, and tissue repair, but face evolving regulatory scrutiny.

Area of Science:

  • Regenerative Medicine
  • Immunotherapy
  • Biotechnology

Background:

  • Advances in understanding cellular processes like activation, plasticity, and differentiation fuel progress in cellular therapies.
  • Improved technologies in cell culture, separation, and recombinant growth factors enhance the efficacy and application of these therapies.
  • Current applications include targeted T lymphocytes for post-transplant cancer and viral infections, and pancreatic islet cells for Type 1 diabetes.

Discussion:

  • Stem cell plasticity offers potential for repairing tissue damage across various organs.
  • The rapid development of cellular therapies necessitates careful monitoring and regulatory oversight.
  • Adverse events associated with emerging therapies have drawn attention from regulatory bodies like the FDA.

Key Insights:

Related Experiment Videos

  • Cellular therapies are demonstrating significant potential in treating complex diseases.
  • The integration of biological understanding and technological innovation is key to therapeutic success.
  • The therapeutic landscape is rapidly evolving, with stem cell applications expanding.

Outlook:

  • The FDA's evolving regulatory strategy will significantly shape the future of cellular medicine.
  • Continued research into cellular mechanisms will unlock new therapeutic possibilities.
  • Balancing innovation with safety and regulatory compliance is crucial for widespread adoption.